Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.11 - $7.48 $311,000 - $748,000
-100,000 Reduced 71.43%
40,000 $125,000
Q1 2022

May 16, 2022

SELL
$4.88 - $8.56 $631,472 - $1.11 Million
-129,400 Reduced 48.03%
140,000 $1.09 Million
Q4 2021

Feb 14, 2022

SELL
$7.03 - $13.03 $10.3 Million - $19.1 Million
-1,465,800 Reduced 84.47%
269,400 $1.89 Million
Q3 2021

Nov 15, 2021

BUY
$11.11 - $17.84 $5.72 Million - $9.18 Million
514,500 Added 42.15%
1,735,200 $19.6 Million
Q2 2021

Aug 16, 2021

BUY
$13.68 - $22.34 $10.7 Million - $17.5 Million
782,300 Added 178.44%
1,220,700 $22.1 Million
Q1 2021

May 17, 2021

BUY
$9.0 - $63.91 $3.23 Million - $22.9 Million
358,400 Added 448.0%
438,400 $9.97 Million
Q2 2020

Aug 14, 2020

BUY
$5.54 - $10.81 $443,200 - $864,800
80,000 New
80,000 $569,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $770M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.